Cargando…

Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica

General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Rioboó, Enrique, Brotons-Cuixart, Carlos, Ruiz García, Antonio, Villafañe Sanz, Fátima, Frías Vargas, Manuel, Moyá Amengual, Ana, Divisón Garrote, Juan Antonio, Seoane Vicente, María Cruz, Banegas, José R., Pallarés Carratalá, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ministerio de Sanidad 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541257/
https://www.ncbi.nlm.nih.gov/pubmed/37921403
_version_ 1785113877669740544
author Martín-Rioboó, Enrique
Brotons-Cuixart, Carlos
Ruiz García, Antonio
Villafañe Sanz, Fátima
Frías Vargas, Manuel
Moyá Amengual, Ana
Divisón Garrote, Juan Antonio
Seoane Vicente, María Cruz
Banegas, José R.
Pallarés Carratalá, Vicente
author_facet Martín-Rioboó, Enrique
Brotons-Cuixart, Carlos
Ruiz García, Antonio
Villafañe Sanz, Fátima
Frías Vargas, Manuel
Moyá Amengual, Ana
Divisón Garrote, Juan Antonio
Seoane Vicente, María Cruz
Banegas, José R.
Pallarés Carratalá, Vicente
author_sort Martín-Rioboó, Enrique
collection PubMed
description General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of providing a shared decision-making recommendations between professionals and patients. In this document we present a critical analysis of these guidelines, offering possible solutions that can be implemented in Primary Care. It should be noted that there are positive aspects (lights) such as that the SCORE2 (from forty to sixty-nine years) and SCORE2-OP models (from seventy to eighty-nine years) are based on more current cohorts and measure cardiovascular risk in a more accurately manner. In addition, it is proposed to differentiate different risk thresholds according to age-groups. For sake of practicality, cardiovascular risk can be estimated using different websites with the new computer models. However, among the negative aspects (shadows), it seems to be add complexity implementing nine subgroups of subjects according to their age or level of risk, with a defined thresholds that could cause a substantial increase in the potential number of subjects susceptible to treatment without a clear evidence that supports it. In addition, two-step RF interventions could delay achievement of therapeutic goals, especially in very high-risk patients, diabetics, or patients with cardiovascular disease. Given these limitations, in this document we propose practical recommendations in order to simplify and facilitate the implementation of the guideline in primary care.
format Online
Article
Text
id pubmed-10541257
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Ministerio de Sanidad
record_format MEDLINE/PubMed
spelling pubmed-105412572023-10-06 Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica Martín-Rioboó, Enrique Brotons-Cuixart, Carlos Ruiz García, Antonio Villafañe Sanz, Fátima Frías Vargas, Manuel Moyá Amengual, Ana Divisón Garrote, Juan Antonio Seoane Vicente, María Cruz Banegas, José R. Pallarés Carratalá, Vicente Rev Esp Salud Publica Colaboración Especial General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of providing a shared decision-making recommendations between professionals and patients. In this document we present a critical analysis of these guidelines, offering possible solutions that can be implemented in Primary Care. It should be noted that there are positive aspects (lights) such as that the SCORE2 (from forty to sixty-nine years) and SCORE2-OP models (from seventy to eighty-nine years) are based on more current cohorts and measure cardiovascular risk in a more accurately manner. In addition, it is proposed to differentiate different risk thresholds according to age-groups. For sake of practicality, cardiovascular risk can be estimated using different websites with the new computer models. However, among the negative aspects (shadows), it seems to be add complexity implementing nine subgroups of subjects according to their age or level of risk, with a defined thresholds that could cause a substantial increase in the potential number of subjects susceptible to treatment without a clear evidence that supports it. In addition, two-step RF interventions could delay achievement of therapeutic goals, especially in very high-risk patients, diabetics, or patients with cardiovascular disease. Given these limitations, in this document we propose practical recommendations in order to simplify and facilitate the implementation of the guideline in primary care. Ministerio de Sanidad 2023-08-16 /pmc/articles/PMC10541257/ /pubmed/37921403 Text en https://creativecommons.org/licenses/by-nc-nd/3.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons
spellingShingle Colaboración Especial
Martín-Rioboó, Enrique
Brotons-Cuixart, Carlos
Ruiz García, Antonio
Villafañe Sanz, Fátima
Frías Vargas, Manuel
Moyá Amengual, Ana
Divisón Garrote, Juan Antonio
Seoane Vicente, María Cruz
Banegas, José R.
Pallarés Carratalá, Vicente
Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
title Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
title_full Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
title_fullStr Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
title_full_unstemmed Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
title_short Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
title_sort luces y sombras de la guía europea esc-2021 de prevención de la enfermedad cardiovascular en la práctica clínica
topic Colaboración Especial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541257/
https://www.ncbi.nlm.nih.gov/pubmed/37921403
work_keys_str_mv AT martinriobooenrique lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT brotonscuixartcarlos lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT ruizgarciaantonio lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT villafanesanzfatima lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT friasvargasmanuel lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT moyaamengualana lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT divisongarrotejuanantonio lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT seoanevicentemariacruz lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT banegasjoser lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica
AT pallarescarratalavicente lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica